Development of De Novo Anti-HLA Antibodies in Pediatric Heart Transplant Recipients

被引:0
|
作者
Chen, C. K. [1 ]
Manlhiot, C. [1 ]
Conway, J. [1 ]
Allain-Rooney, T. [1 ]
McCrindle, B. W. [1 ]
Tinckam, K. [2 ]
Dipchand, A. I. [1 ]
机构
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Hlth Network, Multiorgan Transplant Program, Toronto, ON, Canada
来源
关键词
D O I
10.1016/j.healun.2013.01.471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
517
引用
收藏
页码:S193 / S193
页数:1
相关论文
共 50 条
  • [41] When Is the Best Time to Screen for De Novo Donor Specific Anti-HLA Antibodies (DSA) in Low-Risk Renal Transplant Recipients?
    Everly, M.
    Rebellato-deVente, L. M.
    Haisch, C. E.
    Ozawa, M.
    Parker, K.
    Briley, K. P.
    Catrou, P. G.
    Bolin, P.
    Kendrick, W. T.
    Kendrick, S. A.
    Harland, R. C.
    Terasaki, P., I
    TRANSPLANTATION, 2012, 94 (10) : 1190 - 1190
  • [42] Anti-HLA Antibody Composition and Outcomes in Pediatric Heart Transplant Recipients with a Positive Cross-Match.
    Jindra, P.
    Nicholas, S.
    Chappelle, J.
    Humlicek, T.
    Hosek, K.
    Heinle, J.
    Denfield, S.
    Jeewa, A.
    Kerman, R.
    Dreyer, W.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 551 - 551
  • [43] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, Alev
    Oguz, Fatma Savran
    Usta, Sebahat
    Yildirim, Zeynep Yuruk
    Pehlivanoglu, Cemile
    Kekik, Cigdem
    Emre, Sevinc
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1724 - 1724
  • [44] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, A.
    Yildirim, Z. Yuruk
    Pehlivanoglu, C.
    Nayir, A.
    Emre, S.
    Savran, F. Oguz
    Usta, S.
    Kekik, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 125 - 125
  • [45] The Impact of Belatacept on Anti-HLA Antibodies of Highly Sensitized Kidney Transplant Recipients
    Parsons, R.
    Decker, H.
    Pearson, T.
    Larsen, C.
    Bray, R.
    Gebel, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 426 - 426
  • [46] Monitoring anti-HLA class I IgG antibodies in renal transplant recipients
    Aragao, E
    Moura, LA
    Pacheco-Silva, A
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (04) : 836 - 837
  • [47] THE ROLE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES IN LIVER TRANSPLANT RECIPIENTS
    Uenlue, S.
    Lachmann, N.
    Jara, M.
    Ritschl, P. V.
    Weiss, S.
    Chopra, S.
    Denecke, C.
    Gerlach, U.
    Eurich, D.
    Pratschke, J.
    Oelinger, R.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 12 - 12
  • [48] ANTI-HLA ANTIBODIES IN HEART TRANSPLANTATION
    Ho, Eric K.
    Vlad, George
    Colovai, Adriana I.
    Vasilescu, Rodica
    Schwartz, Joseph
    Sondermeijer, Hugo
    Burke, Elizabeth
    Marboe, Charles C.
    Itescu, Silviu
    Suciu-Foca, Nicole
    Mancini, Donna M.
    HUMAN IMMUNOLOGY, 2009, 70 : S25 - S25
  • [49] De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients
    Del Bello, Arnaud
    Congy-Jolivet, Nicolas
    Danjoux, Marie
    Muscari, Fabrice
    Lavayssiere, Laurence
    Esposito, Laure
    Cardeau-Desangles, Isabelle
    Guitard, Joelle
    Dorr, Gaelle
    Milongo, David
    Suc, Bertrand
    Duffas, Jean Pierre
    Alric, Laurent
    Bureau, Christophe
    Guilbeau-Frugier, Celine
    Rostaing, Lionel
    Kamar, Nassim
    TRANSPLANT INTERNATIONAL, 2015, 28 (12) : 1371 - 1382
  • [50] The Impact of De Novo Donor Specific Anti-HLA Antibodies on the 5-Year Renal Transplant Outcome
    Banasik, M.
    Boratynska, M.
    Koscielska-Kasprzak, K.
    Zabinska, M.
    Chudoba, P.
    Patrzalek, D.
    Halon, A.
    Klinger, M.
    TRANSPLANTATION, 2012, 94 (10) : 1051 - 1051